1. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Issue 7 (July 2020) Authors: Garassino, Marina Chiara; Whisenant, Jennifer G; Huang, Li-Ching; Trama, Annalisa; Torri, Valter; Agustoni, Francesco; Baena, Javier; Banna, Giuseppe; Berardi, Rossana; Bettini, Anna Cecilia; Bria, Emilio; Brighenti, Matteo; Cadranel, Jacques; De Toma, Alessandro; Chini, Claudio; Cortellini, Ales... Journal: Lancet oncology Issue: Volume 21:Issue 7(2020) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis. (January 2019) Authors: Agustoni, Francesco; Suda, Kenichi; Yu, Hui; Ren, Shengxiang; Rivard, Christopher J.; Ellison, Kim; Caldwell, Charles; Rozeboom, Leslie; Brovsky, Kristine; Hirsch, Fred R. Journal: Cancer treatment reviews Issue: Volume 72(2019) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience. Issue 19 (2nd September 2022) Authors: Falanga, Francesco; Rinaldi, Pietro; Primiceri, Cristiano; Bortolotto, Chandra; Oneta, Olga; Agustoni, Francesco; Morbini, Patrizia; Saracino, Laura; Eleftheriou, Dimitrios; Sottotetti, Federico; Stella, Giulia Maria Journal: Thoracic cancer Issue: Volume 13:Issue 19(2022) Page Start: 2792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gemcitabine-induced Thrombocytosis as a Potential Predictive Factor in Non-small Cell Lung Cancer: Analysis of 318 Patients. Issue 2 (March 2017) Authors: Canova, Stefania; Cicchiello, Federica; Agustoni, Francesco; Bianchini, Giampaolo; Abbate, Maria Ida; Bidoli, Paolo; Cortinovis, Diego Luigi Journal: Tumori Issue: Volume 103:Issue 2(2017) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations. Issue 2 (May 2015) Authors: Haspinger, Eva Regina; Agustoni, Francesco; Torri, Valter; Gelsomino, Francesco; Platania, Marco; Zilembo, Nicoletta; Gallucci, Rosaria; Garassino, Marina Chiara; Cinquini, Michela Journal: Critical reviews in oncology/hematology Issue: Volume 94:Issue 2(2015) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era. (June 2022) Authors: Catania, Chiara; Piperno, Gaia; Russo, Alessandro; Greco, Carlo; Agustoni, Francesco; Scotti, Vieri; Proto, Claudia; Sangalli, Claudia; Patani, Fabiola; Santacaterina, Anna; Di Pietro Paolo, Marzia; Agresti, Benedetta; Filippi, Andrea Riccardo; Ramella, Sara Journal: Critical reviews in oncology/hematology Issue: Volume 174(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials. (October 2013) Authors: Celio, Luigi; Agustoni, Francesco; Ricchini, Francesca; Dotti, Katia; Niger, Monica; Braud, Filippo De Journal: Future oncology Issue: Volume 9:Number 10(2013) Page Start: 1451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials. (October 2013) Authors: Celio, Luigi; Agustoni, Francesco; Ricchini, Francesca; Dotti, Katia; Niger, Monica; Braud, Filippo De Journal: Future oncology Issue: Volume 9:Number 10(2013) Page Start: 1451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials. (October 2013) Authors: Celio, Luigi; Agustoni, Francesco; Ricchini, Francesca; Dotti, Katia; Niger, Monica; Braud, Filippo De Journal: Future oncology Issue: Volume 9:Number 10(2013) Page Start: 1451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Radiomics features as predictive and prognostic biomarkers in NSCLC. Issue 3 (4th March 2021) Authors: Bortolotto, Chandra; Lancia, Andrea; Stelitano, Chiara; Montesano, Marianna; Merizzoli, Elisa; Agustoni, Francesco; Stella, Giulia; Preda, Lorenzo; Filippi, Andrea Riccardo Journal: Expert review of anticancer therapy Issue: Volume 21:Issue 3(2021) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗